S.3630 - Facilitating Innovation to Fight Coronavirus Act116th Congress (2019-2020) |
|Sponsor:||Sen. Sasse, Ben [R-NE] (Introduced 05/06/2020)|
|Committees:||Senate - Judiciary|
|Latest Action:||Senate - 05/06/2020 Read twice and referred to the Committee on the Judiciary. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed Senate
- Passed House
- To President
- Became Law
Summary: S.3630 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in Senate (05/06/2020)
Facilitating Innovation to Fight Coronavirus Act
This bill provides immunity from civil liability to health care providers for certain actions taken during the COVID-19 (i.e., coronavirus disease 2019) public health emergency and lengthens the terms of certain medical patents related to the treatment of COVID-19.
Specifically, when testing for or treating COVID-19 during the public health emergency, a health care provider may not be held liable in any federal, state, or local civil proceeding for (1) using or modifying a medical device for an unapproved use or indication; (2) practicing without a license or outside of an area of specialty, if instructed to do so by an individual with such a license or within such an area of speciality; or (3) conducting the testing of, or providing treatment to, a patient outside of the premises of standard health care facilities.
Additionally, certain medical patents that are issued with respect to the treatment of COVID-19 are deemed not to begin until the termination of the presidential emergency declaration relating to COVID-19 and are extended for an additional 10 years.